Stock Events

Stock Events

Stablecoin Development 

$1.45
94
-$0.03-2.03% Friday 19:59

Statistics

Day High
1.54
Day Low
1.41
52W High
99.75
52W Low
1.11
Volume
304,025
Avg. Volume
-
Mkt Cap
156.67M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Sep 25
$4
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

6AugExpected
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q3 2025
Q1 2026
Next
-1.15
0.34
1.84
3.33
Expected EPS
-0.55
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SDEV. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Ocular Therapeutix
OCUL
Mkt Cap1.8B
Ocular Therapeutix focuses on developing treatments for eye diseases, directly competing with Novabay's eye care products.
National Vision
EYE
Mkt Cap1.37B
National Vision Holdings operates in the eye care market, offering products that can be seen as alternatives to Novabay's offerings.
Alcon
ALC
Mkt Cap33.06B
Alcon specializes in eye care products, including surgical, vision care, and ophthalmic pharmaceuticals, competing across several of Novabay's key areas.
Johnson & Johnson
JNJ
Mkt Cap564.11B
Johnson & Johnson, through its Vision Care division, competes in the eye health sector, offering products that rival Novabay's.
Pfizer
PFE
Mkt Cap147.62B
Pfizer has a broad range of healthcare products, including treatments for eye conditions that compete with Novabay's pharmaceuticals.
Novartis
NVS
Mkt Cap290.05B
Novartis offers a wide range of healthcare products, including ophthalmic solutions that compete with Novabay's eye care products.
Bausch Health Companies
BHC
Mkt Cap2.04B
Bausch Health Companies, through its eye health division, directly competes with Novabay in the ophthalmology and optometry markets.
Regeneron Pharmaceuticals
REGN
Mkt Cap66.98B
Regeneron Pharmaceuticals is involved in developing treatments for eye diseases, offering products that compete with Novabay's portfolio.
Abbvie
ABBV
Mkt Cap381.1B
AbbVie, having acquired Allergan, competes in the eye care sector with a portfolio that includes treatments for various eye conditions, challenging Novabay's market share.

About

Stablecoin Development Corp. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase and DERMAdoctor. The company was founded on January 19, 2000 and is headquartered in Emeryville, CA.
Show more...
CEO
Mr. Michael Kazley
Employees
4
Country
United States
ISIN
US66987P5089

Listings

STU
DE
B9P1.STU
XASE
US
SDEV
MU
DE
B9P1.MU
XASE
US
NBY

0 Comments

Share your thoughts

FAQ

What is Stablecoin Development stock price today?▼
The current price of SDEV is $1.45 USD — it has decreased by -2.03% in the past 24 hours. Watch Stablecoin Development stock price performance more closely on the chart.
What is Stablecoin Development stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Stablecoin Development stocks are traded under the ticker SDEV.
What is Stablecoin Development market cap?▼
Today Stablecoin Development has the market capitalization of 156.67M
When is the next Stablecoin Development earnings date?▼
Stablecoin Development is going to release the next earnings report on August 06, 2026.
What were Stablecoin Development earnings last quarter?▼
SDEV earnings for the last quarter are 3.33 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
Does Stablecoin Development pay dividends?▼
Yes, SDEV dividends are paid en. The last dividend per share was 4 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Stablecoin Development have?▼
As of May 26, 2026, the company has 4 employees.
In which sector is Stablecoin Development located?▼
Stablecoin Development operates in the Other sector.
When did Stablecoin Development complete a stock split?▼
The last stock split for Stablecoin Development was on February 23, 2026 with a ratio of 1:5.
Where is Stablecoin Development headquartered?▼
Stablecoin Development is headquartered in EmeryVille, United States.